Overexpression of CXCL3 can enhance the oncogenic potential of prostate cancer.
Gui SL, Teng LC, Wang SQ, Liu S, Lin YL, Zhao XL, Liu L, Sui HY, Yang Y, Liang LC, Wang ML, Li XY, Cao Y, Li FY, Wang WQ.
Gui SL, et al.
Int Urol Nephrol. 2016 May;48(5):701-9. doi: 10.1007/s11255-016-1222-2. Epub 2016 Feb 2.
Int Urol Nephrol. 2016.
PMID: 26837773